Table 1

Patient characteristics

N (%) or median (IQR)
Total (N=256)Brain death (N=56)PAE (N=200)P value
Age, years63 (53–75)58 (45–65)65 (55–76)<0.001
Male167 (65.2)32 (57.1)135 (67.5)0.20
OHCA214 (83.6)50 (89.3)164 (82.0)0.20
Public place at CA129 (50.4)34 (60.7)95 (47.5)0.08
Arrest witnessed/monitored199 (77.7)36 (64.3)163 (81.5)0.006
Bystander CPR64 (25.0)13 (23.2)51 (25.5)0.70
Shockable first recorded rhythm83 (32.4)9 (16.1)74 (37.0)0.003
Total number of defibrillations before ROSC0 (0–2.0)0 (0–2.0)0 (0–2.3)0.053
Use of epinephrine222 (86.7)49 (87.5)173 (86.5)0.80
Total epinephrine dose before ROSC, mg3.0 (1.0–5.0)3.0 (1.0–5.0)3.0 (1.9–4.0)0.50
Time from CA to CPR (no-flow), min5 (0–11)6 (2–15)5 (0–10)0.30
Time from CA to ROSC (low-flow), min21 (15–30)26 (20–36)20 (15–30)0.006
No-flow+low-flow, min (n=245)30 (20–40)36 (28–45)30 (20–37)0.001
Cerebral oedema on initial CT scan (n=120)36/120 (30.0)18/32 (56.3)18/88 (20.5)<0.001
Time to CT scan, hours after CA3 (2–11)3 (2–11)3 (2–4)0.4
Lactate concentration on ICU admission, mmol/L5.7 (3.2–8.1)6.4 (4.8–9.4)5.4 (2.9–7.5)0.003
Final identified cause of CA<0.001
 Cardiac95 (37.1)15 (26.8)80 (40.0)
 Respiratory62 (24.4)11 (19.6)51 (25.5)
 Neurological17 (6.6)11 (19.6)6 (3.0)
 Hanging22 (8.6)9 (16.1)13 (6.5)
 Other60 (23.4)10 (17.9)50 (25.0)
First temperature at admission, °C36.2 (36.0–37.0)36.0 (34.5–36.9)36.3 (35.1–37.2)0.11
TTM213 (83.2)38 (67.9)175 (87.5)<0.001
 Time to TTM target, hours after CA6 (3-7)5 (3-10)6 (3-9)0.9
 Duration of TTM, hours26 (20–31)25 (20–29)26 (20–32)0.40
 TTM>12 hours192 (75.0)34 (60.7)158 (79.0)0.005
 TTM≥24 hours139 (54.3)25 (44.6)114 (57.0)0.10
  33°C110/139 (79.1)19/25 (76.0)91/114 (79.8)0.7
  36°C29/139 (20.9)6/25 (24.0)23/114 (20.2)0.70
Body temperature between days 1 and 2 after admission, °C
 Minimal33.0 (32.1–34.0)33.0 (31.9–34.5)33.0 (32.1–34.0)0.70
 Maximal37.0 (36.4–37.9)37.4 (36.7–38.0)37.0 (36.4–37.8)0.028
PaCO2 between days 1 and 2 after admission, mm Hg
 Minimal29.0 (26.0–32.0)29.0 (26.5–35.0)29.0 (26.0–33.0)0.50
 Maximal45.0 (39.0–54.0)50.0 (42.0–59.0)44.0 (39.0–52.0)0.009
Natraemia between days 1 and 2 after admission, mmol/L
 Minimal137.0 (134.8–140.0)138.0 (135.0–142.0)137.0 (134.0–140.0)0.078
 Maximal143.5 (139.0–146.0)145.0 (141.0–148.0)143.0 (139.0–144.0)<0.001
MAP between days 1 and 2 after admission, mm Hg
 Minimal59 (51–64)57 (50–62)59 (51–64)0.30
 Maximal114 (102–128)124 (106–141)113 (101–125)0.004
Post-resuscitation shock188 (73.4)42 (75.0)146 (73.0)0.80
Continued epinephrine use100 (39.1)26 (46.4)74 (37.0)0.20
Renal replacement therapy37 (14.5)5 (8.9)32 (16.0)0.20
Time between admission and death, days*6 (4–9)4 (2–5)7 (5–9)<0.001
  • *Time between admission and death corresponds to the date of brain death diagnosis in BD patients.

  • CA, cardiac arrest; CPR, cardiopulmonary resuscitation; ICU, intensive care unit; MAP, mean arterial pressure; OHCA, out-of-hospital cardiac arrest; PaCO2, arterial partial pressure of carbon dioxide; PAE, postanoxic encephalopathy; ROSC, return of spontaneous circulation; TTM, targeted temperature management.